Emerging role for the voltage-dependent K+channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy-Reference-Cited by-同舟云学术

Emerging role for the voltage-dependent K+channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy

Published:2013-10 Issue:4 Volume:94 Page:779-789
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Vallejo-Gracia Albert,Bielanska Joanna,Hernández-Losa Javier,Castellví Josep,Ruiz-Marcellan M. Carmen,Ramón y Cajal Santiago,Condom Enric,Manils Joan,Soler Concepció,Comes Núria,Ferreres Joan Carles,Felipe Antonio

Funder

Ministerio de Economía y Competitividad

C.S.

MINECO

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.0213094/fullpdf

Reference48 articles.

1. The functional network of ion channels in T lymphocytes;Cahalan;Immunol. Rev.,2009

2. Potassium channels, memory T cells, and multiple sclerosis;Beeton;Neuroscientist,2005

3. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis;Rangaraju;Expert Opin. Ther. Targets,2009

4. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages;Vicente;J. Biol. Chem.,2003

5. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages;Vicente;J. Biol. Chem.,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kv1.3 in the spotlight for treating immune diseases;Expert Opinion on Therapeutic Targets;2024-02

2. KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo;Cell Death Discovery;2023-10-19

3. SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?;Biochemical Pharmacology;2023-10

4. Potassium Ion Channels in Malignant Central Nervous System Cancers;Cancers;2022-09-29

5. Potassium Channels as a Target for Cancer Therapy: Current Perspectives;OncoTargets and Therapy;2022-07